Search
Ascendis Pharma A/S
ASNDAdd to Watchlist
261.580USD
+23.570+9.90%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
16.21BMarket Cap
37.69P/E TTM
Ascendis Pharma A/S Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
854.80M
126.42%
EPS(YoY)
-4.42
34.64%
Analyst Rating
STRONG BUY
2026-06-25
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its total revenue reached 854.80M, with a year-on-year change of 126.42.
What are the current assets of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its current assets were 1.32B, with a year-on-year change of 19.52.
What are the total assets of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its total assets of Ascendis Pharma A/S were 1.55B, with a year-on-year change of 26.26.
What are the total liabilities of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its total liabilities of Ascendis Pharma A/S were 1.74B, with a year-on-year change of 30.36.
What is the total equity of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its total equity of Ascendis Pharma A/S was -193.27M, with a year-on-year change of -76.11.
What is the net investment of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its net investment of Ascendis Pharma A/S was -10.07M, with a year-on-year change of -241.09.
What is the net financing of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its net financing of Ascendis Pharma A/S was 43.12M, with a year-on-year change of -90.64.
What is the Earnings Per Share (EPS) of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its Earnings Per Share (EPS) was -4.42, with a year-on-year change of 34.64.
What is the net margin of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its net profit margin was -31.67, with a year-on-year change of 69.54.
What is the gross margin of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its gross margin was 86.82, with a year-on-year change of -1.15.
What is the debt-to-asset ratio of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its debt-to-asset ratio was 66.93, with a year-on-year change of -7.85.
What is the Return on Assets (ROA) of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its Return on Assets (ROA) was -18.37, with a year-on-year change of 51.28.
What is the operating profit of Ascendis Pharma A/S?
According to Ascendis Pharma A/S's FY2025 earnings report, its operating profit was -161.75M, with a year-on-year change of 44.11.
